Bafna Pharmaceuticals fundamental analysis
BAFNAPH
242.45
4.75 (2.00%)Last updated on 21 Aug, 2026 | 15:14 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Bafna Pharmaceuticals Score Card
Price
Attractive
Growth
Good
Quality
Average
Management
Poor
On its scorecard, Bafna Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Average, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
Bafna Pharmaceuticals Associated Pages
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BAFNAPH
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC